What dermatologists do not know about smallpox vaccination: results from a worldwide electronic survey

The Journal of Investigative Dermatology
Robert P DellavalleWilliam L Weston

Abstract

The risk of a bioterrorist attack with smallpox has increased owing to breakthroughs in the de novo synthesis of long-chain DNA molecules. Although the leading roles of dermatologists in diagnosing recent outbreaks of cutaneous anthrax and monkeypox demonstrate the importance of dermatologist preparedness for bioterrorism, dermatologist knowledge regarding smallpox vaccination has not been extensively examined. We conducted a cross-sectional worldwide electronic survey of all members of the American Academy of Dermatology with available e-mail addresses. The response rate was 23% (1,303/5,723): 34% of respondents were women, 52% were age 50 or older, 85% practiced in the US, and 90% reported English as their primary language. Less than 37% indicated the Centers for Disease Control and Prevention estimated rate of death owing to smallpox vaccination (1 in 1,000,000), and many failed to identify vaccination contraindications: previous myocardial infarction (83%), angina (83%), congestive heart failure (78%), steroid eye drop use (65%), and the non-emergency vaccination of those younger than age 18 (95%). Widespread dermatologist smallpox vaccination knowledge deficits pinpoint opportunities for educational efforts.

References

Nov 22, 1997·Journal of Clinical Epidemiology·D A AschN A Christakis
Dec 24, 2002·The New England Journal of Medicine·Robert J BlendonKathleen J Weldon
Sep 26, 2003·Family Practice·Dejana BraithwaiteStephen Sutton
Jan 30, 2004·Journal of General Internal Medicine·Andrea L BeninEric S Holmboe
Oct 28, 2004·Health Affairs·Daniel J Kuhles, David M Ackman
Dec 24, 2004·Nature·Jingdong TianGeorge Church
Mar 12, 2005·Science·Jocelyn Kaiser
Apr 9, 2005·Clinical and Diagnostic Laboratory Immunology·Shuji HatakeyamaShigeru Morikawa
Jun 28, 2005·Academic Medicine : Journal of the Association of American Medical Colleges·Elizabeth Armstrong, Ramin Parsa-Parsi
Aug 30, 2005·Annals of Emergency Medicine·UNKNOWN National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group
Dec 8, 2005·JAMA : the Journal of the American Medical Association·Christine G CaseyGina Mootrey

❮ Previous
Next ❯

Citations

Mar 25, 2011·Environmental Health and Preventive Medicine·Hajime SatoEmiko Iwasaki
Apr 19, 2011·Journal of the American Academy of Dermatology·Kalpana Reddy, Eve J Lowenstein
Mar 4, 2009·Dermatologic Clinics·Adam AsarchRobert P Dellavalle
Oct 10, 2008·Journal of the American Academy of Dermatology·Joi Carter, Kathryn A Zug
Jan 30, 2009·Clinical and Experimental Dermatology·V G HubbardS L Walker
Jul 1, 2009·American Journal of Audiology·Melody R MathewsJeffrey L Danhauer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Vincent A FulginitiD A Henderson
Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science
Nkuchia M M'ikanathaEbbing Lautenbach
The Journal of Family Practice
Frederick M ChenHelen Burstin
Emerging Infectious Diseases
David N DurrheimJohn B Lowe
© 2021 Meta ULC. All rights reserved